The global epidemiology of carbapenemase-producing Enterobacteriaceae
- PMID: 27593176
- PMCID: PMC5477705
- DOI: 10.1080/21505594.2016.1222343
The global epidemiology of carbapenemase-producing Enterobacteriaceae
Abstract
Carbapenemase-producing Enterobacteriaceae (CPE) are an important and increasing threat to global health. Both clonal spread and plasmid-mediated transmission contribute to the ongoing rise in incidence of these bacteria. Among the 4 classes of β-lactamases defined by the Ambler classification system, the carbapenemases that confer carbapenem resistance in Enterobacteriaceae belong to 3 of them: Class A (K. pneumoniae carbapenemases, KPC), Class B (metallo-β-lactamases, MBL including New Delhi metallo-β-lactamases, NDM) and Class D (OXA-48-like carbapenemases). KPC-producing CPE are the most commonly occurring CPE in the United States. MBL-producing CPE have been most commonly associated with the Indian Subcontinent as well as with specific countries in Europe, including Romania, Denmark, Spain, and Hungary. The epicenter of OXA-48-like-producing is in Turkey and surrounding countries. Detailed knowledge of the epidemiology and molecular characteristics of CPE is essential to stem the spread of these pathogens.
Keywords: carbapenem-resistant Enterobacteriaceae; carbapenemases; epidemiology; global; plasmid.
Similar articles
-
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.Int J Antimicrob Agents. 2018 Mar;51(3):511-515. doi: 10.1016/j.ijantimicag.2018.01.011. Epub 2018 Jan 31. Int J Antimicrob Agents. 2018. PMID: 29371104
-
Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.J Infect Public Health. 2019 Mar-Apr;12(2):270-274. doi: 10.1016/j.jiph.2018.11.003. Epub 2018 Nov 23. J Infect Public Health. 2019. PMID: 30477920
-
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.Euro Surveill. 2015;20(45). doi: 10.2807/1560-7917.ES.2015.20.45.30062. Euro Surveill. 2015. PMID: 26675038
-
[Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].Med Monatsschr Pharm. 2014 May;37(5):162-72; quiz 173-4. Med Monatsschr Pharm. 2014. PMID: 24908928 Review. German.
-
Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?Enferm Infecc Microbiol Clin. 2014 Dec;32 Suppl 4:17-23. doi: 10.1016/S0213-005X(14)70170-3. Enferm Infecc Microbiol Clin. 2014. PMID: 25542048 Review.
Cited by
-
Association between multidrug-resistant bacteria and outcomes in intensive care unit patients: a non-interventional study.Front Public Health. 2024 Jan 8;11:1297350. doi: 10.3389/fpubh.2023.1297350. eCollection 2023. Front Public Health. 2024. PMID: 38259738 Free PMC article.
-
Performance Evaluation of the Newly Developed In Vitro Rapid Diagnostic Test for Detecting OXA-48-Like, KPC-, NDM-, VIM- and IMP-Type Carbapenemases: The RESIST-5 O.K.N.V.I. Multiplex Lateral Flow Assay.Antibiotics (Basel). 2021 Apr 19;10(4):460. doi: 10.3390/antibiotics10040460. Antibiotics (Basel). 2021. PMID: 33921669 Free PMC article.
-
Detection of a New Resistance-Mediating Plasmid Chimera in a blaOXA-48-Positive Klebsiella pneumoniae Strain at a German University Hospital.Microorganisms. 2021 Mar 31;9(4):720. doi: 10.3390/microorganisms9040720. Microorganisms. 2021. PMID: 33807212 Free PMC article.
-
High prevalence of carbapenem-resistant Enterobacterales (CRE) in human samples from Nigeria: A systematic review and meta-analysis.Heliyon. 2024 Jul 20;10(15):e34926. doi: 10.1016/j.heliyon.2024.e34926. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39144932 Free PMC article.
-
Systematic Comparison of Three Commercially Available Combination Disc Tests and the Zinc-Supplemented Carbapenem Inactivation Method (zCIM) for Carbapenemase Detection in Enterobacterales Isolates.J Clin Microbiol. 2021 Aug 18;59(9):e0314020. doi: 10.1128/JCM.03140-20. Epub 2021 Aug 18. J Clin Microbiol. 2021. PMID: 34133894 Free PMC article.
References
-
- Organization WH Antimicrobial Resistance: Global Report on Surveillance. 2014; http://wwwwhoint/drugresistance/documents/surveillancereport/en/
-
- Centers for Disease Control and Prevention ANTIBIOTIC RESISTANCE THREATS in the United States, 2013. 2013; http://wwwcdcgov/drugresistance/threat-report-2013/
-
- van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: Trends and lessons learned. Infect Dis Clin North Am 2016; 30:377-90; PMID:27208764; https://doi.org/ 10.1016/j.idc.2016.02.004 - DOI - PMC - PubMed
-
- Khatri A, Naeger Murphy N, Wiest P, Osborn M, Garber K, Hecker M, Hurless K, Rudin SD, Jacobs MR, Kalayjian RC, et al.. Community-Acquired Pyelonephritis in Pregnancy Caused by KPC-Producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2015; 59:4375-8; PMID:26185273; https://doi.org/ 10.1128/AAC.00553-15 - DOI - PMC - PubMed
-
- van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 2013; 75:115-20; PMID:23290507; https://doi.org/ 10.1016/j.diagmicrobio.2012.11.009 - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous